Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Mass Screening × Thoracic × Clear all

Phase

Status

Completed 2 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 Gastrointestinal 1 Breast 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 113 pembrolizumab 109 Pemetrexed 81 Cisplatin 76 durvalumab 62 osimertinib 52 Paclitaxel 52 Nivolumab 50 atezolizumab 39 Docetaxel 39 Radiosurgery 25 Etoposide 25 Radiotherapy 23 Specimen Handling 22 Gemcitabine 22 Ipilimumab 20 Magnetic Resonance Spectroscopy 18 Taxes 17 Platinum 15 Bevacizumab 15 Radiation 14 130-nm albumin-bound paclitaxel 14 Drug Therapy 13 amivantamab 12 Immunoglobulin G 12 Disulfides 12 Cyclophosphamide 12 Crizotinib 12 tislelizumab 11 1,2-diaminocyclohexaneplatinum II citrate 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02247453 2024-03-07

BIOMILD

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Active not recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡